(Q46620385)

English

Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits (English)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

0 references

meningococcal disease

1 reference

based on heuristic

inferred from title

author name string

Cox AD

1

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Zou W

2

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Gidney MA

3

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Lacelle S

4

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Plested JS

5

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Makepeace K

6

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Wright JC

7

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Coull PA

8

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Moxon ER

9

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Richards JC

10

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

23

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

43

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

5045-5054

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Highly ConservedNeisseria meningitidisInner‐Core Lipopolysaccharide Epitope Confers Protection against Experimental Meningococcal Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Conjugation of meningococcal lipooligosaccharides through their lipid A terminus conserves their inner epitopes and results in conjugate vaccines having improved immunological properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Functional relationships of the genetic locus encoding the glycosyltransferase enzymes involved in expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Identification of a novel inner‐core oligosaccharide structure in Neisseria meningitidis lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.06.011

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.06.011

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

1 reference

Europe PubMed Central

23 December 2017

http://europepmc.org/abstract/MED/16046037

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46620385&oldid=2122647894"